A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects

Conditions:   Anesthesia;   Sedation Intervention:   Drug: HSK3486 Sponsor:   Sichuan Haisco Pharmaceutical Group Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials